Nurix Therapeutics, Inc.
Total Trades
150
Buys
0
Sells
81
Largest Trade
N/A
Insiders
4
Institutional Funds
134
Inst. Value
$1M+
Activist Filings
43
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| van Houte Hans | CFO | SELL | $1K–$15K | 1K | $9.65 | Aug 1, 2023 |
| van Houte Hans | CFO | EXERCISE | N/A | 5K | — | Aug 1, 2023 |
| Ring Christine | General Counsel | SELL | $1K–$15K | 1K | $9.65 | Aug 1, 2023 |
| Ring Christine | General Counsel | EXERCISE | N/A | 4K | — | Aug 1, 2023 |
| Hansen Gwenn | Chief Scientific O… | EXERCISE | N/A | 5K | — | Aug 1, 2023 |
| Hansen Gwenn | Chief Scientific O… | SELL | $15K–$50K | 2K | $9.65 | Aug 1, 2023 |
| Wolff Stefani | EVP and COO | EXERCISE | N/A | 962 | — | May 2, 2023 |
| Wolff Stefani | EVP and COO | SELL | $1K–$15K | 342 | $9.88 | May 2, 2023 |
| van Houte Hans | CFO | EXERCISE | N/A | 3K | — | May 2, 2023 |
| van Houte Hans | CFO | SELL | $1K–$15K | 721 | $9.88 | May 2, 2023 |
| Ring Christine | General Counsel | EXERCISE | N/A | 2K | — | May 2, 2023 |
| Ring Christine | General Counsel | SELL | $1K–$15K | 682 | $9.88 | May 2, 2023 |
| Hansen Gwenn | Chief Scientific O… | SELL | $1K–$15K | 1K | $9.88 | May 2, 2023 |
| Hansen Gwenn | Chief Scientific O… | EXERCISE | N/A | 3K | — | May 2, 2023 |
| Wolff Stefani | EVP and COO | EXERCISE | N/A | 962 | — | Feb 1, 2023 |
| Wolff Stefani | EVP and COO | SELL | $1K–$15K | 424 | $11.78 | Feb 1, 2023 |
| van Houte Hans | CFO | SELL | $1K–$15K | 924 | $11.78 | Feb 1, 2023 |
| van Houte Hans | CFO | EXERCISE | N/A | 3K | — | Feb 1, 2023 |
| Ring Christine | General Counsel | SELL | $1K–$15K | 848 | $11.78 | Feb 1, 2023 |
| Ring Christine | General Counsel | EXERCISE | N/A | 2K | — | Feb 1, 2023 |
| Hansen Gwenn | Chief Scientific O… | EXERCISE | N/A | 3K | — | Feb 1, 2023 |
| Hansen Gwenn | Chief Scientific O… | SELL | $15K–$50K | 1K | $11.78 | Feb 1, 2023 |
| van Houte Hans | CFO | SELL | $1K–$15K | 739 | $12.88 | Nov 1, 2022 |
| van Houte Hans | CFO | EXERCISE | N/A | 3K | — | Nov 1, 2022 |
| Ring Christine | General Counsel | SELL | $1K–$15K | 699 | $12.88 | Nov 1, 2022 |
| Ring Christine | General Counsel | EXERCISE | N/A | 2K | — | Nov 1, 2022 |
| Hansen Gwenn | Chief Scientific O… | SELL | $15K–$50K | 1K | $12.88 | Nov 1, 2022 |
| Hansen Gwenn | Chief Scientific O… | EXERCISE | N/A | 3K | — | Nov 1, 2022 |
| Wolff Stefani | EVP and COO | EXERCISE | N/A | 962 | — | Nov 1, 2022 |
| Wolff Stefani | EVP and COO | SELL | $1K–$15K | 350 | $12.88 | Nov 1, 2022 |
| Ring Christine | General Counsel | SELL | $1K–$15K | 712 | $15.67 | Aug 2, 2022 |
| Ring Christine | General Counsel | EXERCISE | N/A | 2K | — | Aug 2, 2022 |
| Wolff Stefani | EVP and COO | SELL | $1K–$15K | 356 | $15.67 | Aug 2, 2022 |
| Wolff Stefani | EVP and COO | EXERCISE | N/A | 962 | — | Aug 2, 2022 |
| van Houte Hans | CFO | EXERCISE | N/A | 3K | — | Aug 2, 2022 |
| van Houte Hans | CFO | SELL | $1K–$15K | 752 | $15.67 | Aug 2, 2022 |
| Hansen Gwenn | Chief Scientific O… | SELL | $15K–$50K | 1K | $15.67 | Aug 2, 2022 |
| Hansen Gwenn | Chief Scientific O… | EXERCISE | N/A | 3K | — | Aug 2, 2022 |
| Hansen Gwenn | Chief Scientific O… | EXERCISE | N/A | 3K | — | May 3, 2022 |
| Hansen Gwenn | Chief Scientific O… | SELL | $1K–$15K | 1K | $11.75 | May 3, 2022 |
| Wolff Stefani | EVP and COO | SELL | $1K–$15K | 330 | $11.75 | May 3, 2022 |
| Wolff Stefani | EVP and COO | EXERCISE | N/A | 962 | — | May 3, 2022 |
| van Houte Hans | CFO | SELL | $1K–$15K | 697 | $11.75 | May 3, 2022 |
| van Houte Hans | CFO | EXERCISE | N/A | 3K | — | May 3, 2022 |
| Ring Christine | General Counsel | EXERCISE | N/A | 2K | — | May 3, 2022 |
| Ring Christine | General Counsel | SELL | $1K–$15K | 660 | $11.75 | May 3, 2022 |
| Ring Christine | General Counsel | SELL | $15K–$50K | 1K | $27.14 | Jan 11, 2022 |
| Ring Christine | General Counsel | EXERCISE | $1K–$15K | 1K | $1.86 | Jan 11, 2022 |
| Hansen Gwenn | Chief Scientific O… | EXERCISE | $15K–$50K | 2K | $9.06 | Jan 4, 2022 |
| Hansen Gwenn | Chief Scientific O… | SELL | $50K–$100K | 2K | $28.96 | Jan 4, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 134 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Redmile Group, LLC | 8.1M | $1M+ | SH |
| Deep Track Capital, LP | 7.0M | $1M+ | SH |
| STATE STREET CORP | 3.6M | $1M+ | SH |
| PERCEPTIVE ADVISORS LLC | 3.6M | $1M+ | SH |
| Pictet Asset Management Holding SA | 3.5M | $1M+ | SH |
| Point72 Asset Management, L.P. | 3.2M | $1M+ | SH |
| DEUTSCHE BANK AG\ | 2.5M | $1M+ | SH |
| Rubric Capital Management LP | 2.5M | $1M+ | SH |
| BRAIDWELL LP | 2.2M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 2.1M | $1M+ | SH |
| Trails Edge Capital Partners, LP | 1.7M | $1M+ | SH |
| ARK Investment Management LLC | 1.6M | $1M+ | SH |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.3M | $1M+ | SH |
| Sumitomo Mitsui Trust Group, Inc. | 1.3M | $1M+ | SH |
| Amova Asset Management Americas, Inc. | 1.3M | $1M+ | SH |
| Soleus Capital Management, L.P. | 1.2M | $1M+ | SH |
| Affinity Asset Advisors, LLC | 968K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 966K | $1M+ | SH |
| Longaeva Partners L.P. | 928K | $1M+ | SH |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 735K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 17, 2026
7.2%
7.5M shares
SC 13G/A · Nov 14, 2025
4.9%
3.8M shares
SC 13G/A · Nov 7, 2025
4.1%
4.2M shares
SC 13G/A · Nov 5, 2025
11.5%
8.8M shares
SC 13G/A · May 15, 2025
7.2%
5.5M shares
SC 13G/A · May 12, 2025
13.4%
10.2M shares
SC 13G/A · Apr 24, 2025
8.2%
6.3M shares
SC 13G · Feb 14, 2025
5.4%
4.1M shares
SC 13G · Feb 14, 2025
5.1%
3.9M shares
SC 13G/A · Feb 14, 2025
4.2%
3.0M shares
SC 13G/A · Jan 11, 2025
0.0%
0 shares
SC 13G · Dec 6, 2024
14.5%
10.3M shares
SC 13G/A · Nov 15, 2024
9.9%
7.0M shares
SC 13G/A · Nov 14, 2024
9.7%
6.8M shares
SC 13G/A · Nov 14, 2024
4.7%
3.3M shares
Wasatch Advisors LP 87-0319391
SC 13G/A · Nov 14, 2024
1.1%
708K shares
Wellington Management Group LLP
SC 13G · Nov 8, 2024
5.4%
3.5M shares
Morgan Stanley I.R.S. # 36-3145972
SC 13G/A · Nov 7, 2024
2.7%
1.8M shares
SC 13G/A · Jun 7, 2024
10.2%
6.0M shares
SC 13G/A · Feb 14, 2024
9.9%
5.0M shares
SC 13G/A · Feb 14, 2024
10.0%
5.0M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2024
4.9%
2.4M shares
SC 13G/A · Feb 14, 2024
6.2%
3.0M shares
SC 13G · Feb 14, 2024
5.4%
2.7M shares
The Vanguard Group - 23-1945930
SC 13G · Feb 13, 2024
5.4%
2.6M shares
SC 13G · Jan 29, 2024
6.6%
3.2M shares
SC 13G/A · Jan 24, 2024
9.6%
4.6M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Jan 23, 2024
1.9%
0 shares
SC 13G · Feb 24, 2023
5.8%
2.7M shares
SC 13G/A · Feb 14, 2023
9.9%
4.9M shares
SC 13G/A · Feb 14, 2023
0.0%
0 shares
SC 13G/A · Feb 14, 2023
10.0%
4.8M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2023
6.9%
3.3M shares
SC 13G/A · Feb 14, 2023
4.8%
2.3M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G · Feb 10, 2023
5.3%
0 shares
SC 13G/A · Jan 25, 2023
8.8%
4.1M shares
SC 13G · Jun 10, 2022
5.2%
2.4M shares
SC 13G/A · Feb 14, 2022
6.6%
3.0M shares
SC 13G/A · Feb 14, 2022
5.4%
2.4M shares
SC 13G · Feb 14, 2022
5.5%
2.5M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2022
10.9%
4.9M shares
SC 13G/A · Feb 11, 2022
0.0%
0 shares
Foresite Capital Fund IV, L.P. (“FCF IV”)
SC 13G/A · Feb 11, 2022
2.7%
1.2M shares